key: cord-1007377-mqhgtyck
authors: Zahar, Jean-Ralph; Allaouchiche, Bernard
title: Even vaccinated against COVID-19, we must continue to wear a mask
date: 2021-03-23
journal: Anaesth Crit Care Pain Med
DOI: 10.1016/j.accpm.2021.100849
sha: d0ae4fb192cc6833566704544d3c86a47528a4b6
doc_id: 1007377
cord_uid: mqhgtyck

nan

Given the reproduction rate number (R0), estimated at between 2.5 and 3.5, and considering the availability of the vaccines, only herd immunity reaching (1-1/R0) between 60 and 72% of the population will make it possible to limit the circulation of the virus.

Nonetheless, through this crisis we first have learned that there is no specific antiviral treatment [1] [2] . On the other hand, we know preventive measures are vital in limiting the spread, as is the case in the majority of respiratory viral infections. Hence, they are only two ways to reduce the risk in the hospital: vaccination and universal masking. However, we are far from having reached a high percentage of vaccination that would allow us to achieve sufficient herd immunity [3] . So, should we continue to wear a mask, and for how long?

In this context, it is important to remember that transmission of SARS-CoV2 occurs from both symptomatic and asymptomatic patients with probable different risk of transmission [4] [5] . However, more than 50% of infected patients are either asymptomatic or pre symptomatic [6] . For this reason, in the absence of effective tools to identify this population (i.e., the reservoir), only a universal measure can be used to control the risk; but what about its effectiveness?

Even before the start of the pandemic, many authors had sought to measure the effectiveness of universal masking in reducing the risk of transmission of infectious agents.

Several studies tried to address this question while limiting the evaluation to particular situations. Most of them highlighted a benefit when the measure was initiated early with the identification of the index case and when the latter was associated with hand hygiene. More J o u r n a l P r e -p r o o f recently, a meta-analysis including non-randomised and comparative studies of different means of prevention suggested a reduction by 15% of the risk of transmission linked to the mask. Especially, while in most studies wearing the mask alone did not reduce the risk of acquisition, it was still associated with a concrete reduction in transmission. For example, Leung et al. [7] studied mask use concerning 246 symptomatic people with influenza and seasonal coronavirus. They found a significant reduction in the virus presence by RT-PCR, droplets, and aerosols, for 124 people randomly selected to wear a mask.

While there was a lack of data assessing the value of universal masking in the general population, this pandemic provided an opportunity to evaluate this tool of prevention in a non-immune population. Therefore, at a hair salon in which all staff and clients were asked to wear a mask, 2 symptomatic, infected stylists attended to 139 clients, and no infections were observed in the 67 clients who were reached for interviewing and testing. Also, during an outbreak on the USS Theodore Roosevelt, persons who wore masks experienced a 70% lower risk of testing positive for SARS-CoV-2 infection [8] . 

Several studies conducted during the pandemic suggested that universal masking was associated with a reduction of the risk of infection. A retrospective quasi-experimental study, of all patients, admitted from the 6 th of April 2020 to the 18 th of May 2020 to a large academic referral centre in the South-eastern U.S., showed universal masking decreased the rate of high-risk exposures by 68% per patient [11] . Thus, Wang [12] et al. presented evidence that universal masking of healthcare workers (HCWs) and patients can help reduce transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. In J o u r n a l P r e -p r o o f the largest healthcare system of Massachusetts, authors presented data that before the implementation of universal masking in late March 2020, new infections among HCWs with direct or indirect patient contact were increasing exponentially, from 0% to 21.3% (a mean increase of 1.16% per day). However, once the universal masking policy in place, the proportion of symptomatic HCWs with positive test results steadily declined, from 14.7% to 11.5% (a mean decrease of 0.49% per day). Others (aka) compared the 7-day average incidence rates between a Massachusetts (USA) healthcare system and Massachusetts residents state-wide. The study period was from the 17 th of March to the 6 th of May. The healthcare system implemented universal masking on the 26 th of March. Temporal incidence trends (i.e., 7-day average slopes) were compared using standardised coefficients from linear regression models. The standardised coefficients were similar between the healthcare system and the state in both the pre intervention and epidemic decline phases. During the intervention phase, the healthcare system's epidemic slope became negative (standardised β: −0.68, 95% CI: −1.06 to −0.31), while Massachusetts' slope remained positive (standardised β: 0.99, 95% CI: 0.94 to 1.05) [13] .

The question is no longer whether the universal masking is protective, but how long this measure will be maintained. Indeed, one day it will be necessary to return to standard precautions, but this will depend on several factors, including herd immunity as well as individual risk factors. While recent data on vaccination suggest a significant decrease of symptomatic infections and their severity, some other data cover its role in reducing the risk of asymptomatic infection or re-infection. Indeed, with the emergence and spread of SARS-CoV-2 variants and the recent data suggesting a reduced efficacy of vaccines and a less robust immune protection, we must consider the hypothesis of an increase in cases of re-J o u r n a l P r e -p r o o f infection. It seems obvious to us that this risk will evolve. This is the reason why, while waiting for the data of the upcoming months, vaccinated or not, universal masking, hand hygiene, eye protection, and social distancing are needed to limit the spread of COVID-19.

The vaccine will not fundamentally change the course of the epidemic because it reduces the severity of symptoms, but not contagiousness.

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review

Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel?

Cross-reactive memory T cells and herd immunity to SARS-CoV-2

SARS-CoV-2 settingspecific transmission rates: a systematic review and meta-analysis

Defining the role of asymptomatic and pre-symptomatic SARS-CoV-2 transmission -a living systematic review

The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic Review

Respiratory virus shedding in exhaled breath and efficacy of face masks

Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2

Face Mask Use in the Community for Reducing the Spread of COVID-19: A Systematic Review

The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2

Decreasing High Risk Exposures for Healthcare-workers through Universal Masking and Universal SARS-CoV-2 Testing upon entry to a Tertiary Care Facility

Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers

Effects of universal masking on Massachusetts healthcare workers' COVID-19 incidence